Solid Biosciences Inc
Solid Biosciences Inc (SLDB) Wheel Strategy
SLDB wheel strategy scan found 1 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 262.6%.
Read more
Running a SLDB wheel strategy lets you generate consistent premium income on Solid Biosciences Inc while setting your own entry and exit prices on the underlying. Solid Biosciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own SLDB, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best SLDB wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on SLDB, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable SLDB wheel from a losing one.
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.
to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the SLDB wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your SLDB wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Dec 18, 2026 | 4.00 | $0.05 | $2.48 | -0.08 | 86 | 17% | 80.1% | 262.6% | 1 |
As of September 23, 2026
Run the Wheel on SLDB With Confidence
Find the best SLDB wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→